Quick Links
Operated by
Untitled Document
Theme: Safer Drugs to Market by Analyzing Latest Developments in Pharmacovigilance, Drug Safety and Risk Management


Zhe Sha, Harvard Medical School, USA

Its my real honor to be part of this great conference. I had a truly rewarding experience meeting with many experts in the field.

Jamal Abdel-Halim, Director, Biomarkers, USA

It was my pleasure to participate and speak in this important meeting. I wish we work together again.

Welcome Message

Pharmacovigilance-2013 annual conference reflected the development of Pharmacovigilance, drug safety and clinical trials from a new to a mature industry, highlighting through various sessions how the science is having an impact on society, and how it can generate even greater impact. Following on from the success of last year now it’s time to invite you all for 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials is set to take centre stage once more in Hyderabad India on October 27-29, 2014.

Our conference mainly focused on the Theme “Safer Drugs to Market by Analyzing Latest Developments in Pharmacovigilance, Drug Safety and Risk Management”

Over the last couple of decades, advances in biomedical science have generated more new and complex medicines to treat a broader range of diseases and conditions than ever before. The number of people taking medications has increased dramatically, and, as a result, governments, patient groups and health advocates are demanding stronger regulatory practices and procedures, to assure the safety of medicines before and after they reach the market. 

Hence, as the regulatory landscape continues to evolve it is crucial that you are keeping abreast of the changes impacting the drug safety industry to ensure that your pharmacovigilance strategies are robust and geared to compliance.  In addition to this effective risk management and minimisation efforts and comprehensive benefit: risk analysis of drugs must lay the foundations for a strong drug safety strategy.

Pharmacovigilance-2014 conference is being collaborated with Society of Pharmacovigilance, India and also we will be collaborated with many more in future. This educational 3 day conference provides a unique platform for workshops and sessions you like to address the practical approaches which can take to mitigate risks and maximise patient safety.  A tailored conference will give you the opportunity to share knowledge and expertise and will provide unparalleled networking opportunities with a large number of professionals in this industry sphere.

Conference Highlights

Pharmacovigilance and its Challenges

Role of Clinical Trials

Clinical Trials on Diseases

Adverse Drug Reactions

Pharmacokinetics and Pharmacodynamics

Pharmacy Practices and its Challenges

Risk Management: New Approaching Paradigm for Pharmacovigilance

Clinical Research and Statistics

Strategies for Growth in Pharma Environment

Good Pharmacovigilance Practice and Pharmacoepidemiology

Case Report in Clinical Trials

To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date
October 27-29, 2014
Sponsors & Exhibitors
Speaker Opportunity
Day 1                Day 2                Day 3
Available         Available         Available
Poster Opportunity
Special Issues
All accepted abstracts will be published in respective OMICS Group Journals.
Abstracts will be provided with Digital Object Identifier by
Media Partners
Best viewed in Mozilla Firefox | Google Chrome | Opera | Safari | Above IE 7.0 version